Patients & Caregivers

Care OM™

Caphosol^®

Healthcare Professionals

Care OM™ References

Meraw, Stephen J., and Charles M. Reeve. "Dental Considerations and Treatment of the Oncology Patient Receiving Radiation Therapy." Journal of the American Dental Association 129 (1998): 201-205.
Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004;100(9 Suppl):2026-46. [p. 2031, col 1, para 5]
Köstler WJ, Hejna M, Wenzel C, Zielinski CC. Oral mucositis complicating chemotherapy and/or radiotherapy: options for prevention and treatment. CA Cancer J Clin 2001;51:290-315. [p. 291, col 1, para 1]
Sonis, Stephen T. "Oral Mucositis in Cancer Therapy." Supportive Oncology 2 (2004): 3-8.
Redding, Spencer W. "Cancer Therapy-Related Oral Mucositis." Journal of Dental Education 69 (2005): 919-929.
CAPHOSOL Prescribing Information.
Papas AS, Clark RE, Martuscelli G, O'Loughlin KT, Johansen E, Miller KB. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;8:705-12. [p. 709, col 2, para 6]
On-line Medical Dictionary. Mucositis. Centre for Cancer Education, University of Newcastle upon Tyne. Available at: http://cancerweb.ncl.ac.uk/cgi-bin/omd?query=mucositis. Accessed Jan. 22, 2007.

Important Safety Information: Avoid eating or drinking at least 15 minutes after use. Patients restricted to a low sodium diet should consult their physician before use. Federal law restricts this device to sale by or on the order of a physician or dentist.

Keep out of reach of children. For full prescribing information, please click here.

C-0157-08